VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 538.97B
Enterprise Value 337.92B
Trailing P/E 148.49
Forward P/E 150.19
PEG Ratio (5 yr expected) 11.41
Price/Sales (ttm)18.29
Price/Book (mrq)23.19
Enterprise Value/Revenue 317.79
Enterprise Value/EBITDA 692.76

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin 12.19%
Operating Margin (ttm)16.81%
Management Effectiveness
Return on Assets (ttm)7.67%
Return on Equity (ttm)17.72%
Income Statement
Revenue (ttm)2.13B
Revenue Per Share (ttm)8.66
Quarterly Revenue Growth (yoy)26.10%
Gross Profit (ttm)1.49B
EBITDA 408.78M
Net Income Avi to Common (ttm)259.47M
Diluted EPS (ttm)1.04
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)1.67B
Total Cash Per Share (mrq)6.62
Total Debt (mrq)568.54M
Total Debt/Equity (mrq)30.45
Current Ratio (mrq)3.49
Book Value Per Share (mrq)6.66
Cash Flow Statement
Operating Cash Flow (ttm)657.72M
Levered Free Cash Flow (ttm)537.14M

Trading Information

Stock Price History
Beta 2.10
52-Week Change 389.12%
S&P500 52-Week Change 319.45%
52 Week High 3167.86
52 Week Low 371.46
50-Day Moving Average 3154.36
200-Day Moving Average 3137.17
Share Statistics
Avg Vol (3 month) 31.8M
Avg Vol (10 day) 31.32M
Shares Outstanding 5252.12M
Float 251.11M
% Held by Insiders 10.45%
% Held by Institutions 198.24%
Shares Short 33.65M
Short Ratio 31.32
Short % of Float 31.47%
Shares Short (prior month) 33.73M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Aug 24, 2000